Nifekalant Hydrochloride, a Novel Class III Antiarrhythmic Agent, Suppressed Postoperative Recurrent Ventricular Tachycardia in a Patient Undergoing Coronary Artery Bypass Grafting and the Dor Approach
Sahara M, Sagara K, Yamashita T, Iinuma H, Fu L, Watanabe H. Nifekalant Hydrochloride, a Novel Class III Antiarrhythmic Agent, Suppressed Postoperative Recurrent Ventricular Tachycardia in a Patient Undergoing Coronary Artery Bypass Grafting and the Dor Approach. Circulation Journal 2003, 67: 712. PMID: 12890916, DOI: 10.1253/circj.67.712.Peer-Reviewed Case Reports and Technical NotesConceptsVentricular premature contractionsVentricular tachycardiaNifekalant hydrochlorideAntiarrhythmic agentsPremature contractionsCoronary Artery Bypass GraftingNovel class III antiarrhythmic agentClass III antiarrhythmic agentRecurrent ventricular tachyarrhythmiasArtery Bypass GraftingCoronary artery bypassRecurrent ventricular tachycardiaCoronary artery diseaseClass III drugsArtery bypassBypass GraftingArtery diseaseElectrical cardioversionVentricular aneurysmVentricular tachyarrhythmiasIb drugsChannel blockersElectrical stormTachycardiaDrugs